SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Fund entered into a material definitive investment management agreement with Blackstone Alternative Asset Management L.P. and BXHF Aggregator on July 29, 2026, governing how the Fund will invest substantially all of its assets through the Aggregator and including modifications to management fees and new unit classes.
View raw filing on EDGAR →The Fund entered into a revolving credit agreement on July 30, 2026, creating a new direct financial obligation of up to $20 million, collateralized by investments and distributions, with interest at three-month SOFR plus 1.50% spread plus 0.50% commitment fee, maturing May 15, 2027 with renewal through May 9, 2028.
View raw filing on EDGAR →The Fund issued 5,795,000 unregistered Class IF limited partnership units for approximately $145 million on August 3, 2026, pursuant to Section 4(a)(2) and Regulation D exemptions to accredited investors and qualified purchasers.
View raw filing on EDGAR →Michelle Gilson was appointed to the Board of Directors effective August 1, 2026, and simultaneously appointed as chair of the Audit Committee. This is a clear executive appointment of a director and committee chair with relevant biotechnology and financial expertise. Board appointments and committee leadership changes are material governance events affecting the registrant's leadership structure.
View raw filing on EDGAR →ASP Isotopes disclosed a shareholder letter dated August 4, 2026, providing detailed operational and financial updates across multiple business divisions (PET Labs, Renergen, stable isotopes, QLE, Alpa Theranostics) in advance of the company's announcement of Q2 2026 financial results, including revenue guidance and EBITDA targets.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 financial results. The Item 2.02 disclosure explicitly states "In a press release dated August 4, 2026, NexPoint Residential Trust, Inc. (the "Company") announced financial results for the Company's second quarter ended June 30, 2026." The exhibit contains comprehensive quarterly financial data including net loss, FFO, Core FFO, AFFO, revenues, NOI, and operational metrics, which are typical components of an earnings announcement. Material to investors as it discloses quarterly operating performance and guidance.
View raw filing on EDGAR →PSEG announced second quarter and six-month 2026 financial results on August 4, 2026, reporting net income of $0.67 per share for Q2 2026 and $2.15 per share for the six-month period, along with non-GAAP operating earnings guidance of $4.28–$4.40 per share for full-year 2026.
View raw filing on EDGAR →Nutanix announced a 5% global workforce reduction with estimated pre-tax charges of $33–43 million, primarily severance and termination benefits, to be substantially completed by end of October 2026. This is a classic workforce_reduction disclosure under Item 2.05, combining the operational decision (workforce reduction) with quantified exit costs that would materially affect investor assessment of near-term financial performance and operational efficiency.
View raw filing on EDGAR →Millrose Properties announced Q2 2026 financial results ended June 30, 2026, reporting net income of $125.9 million ($0.76 per share), AFFO of $0.77 per share, and total revenues of $196.9 million. The company also declared a dividend of $0.77 per share.
View raw filing on EDGAR →The filing discloses the declaration of July 2026 dividends for the Fund's common shares, with Class I shares receiving $0.1864 per share, payable on or about August 25, 2026. This is a routine but material dividend distribution to shareholders, which is the primary event disclosed in Item 8.01. The filing also includes supplementary information on NAV and offering status, but the core disclosure is the dividend declaration.
View raw filing on EDGAR →AT&T closed the sale of approximately €4.1 billion and £550 million in aggregate principal amount of Global Notes across five tranches with maturities ranging from 2030 to 2052, issued pursuant to an Underwriting Agreement dated July 27, 2026. This constitutes a material creation of direct financial obligations and is a classic debt issuance disclosure under Item 8.01, creating new debt instruments registered under the Securities Act of 1933.
View raw filing on EDGAR →This is a clear earnings release disclosing Expeditors' second quarter 2026 financial results. The filing explicitly states "On August 4, 2026, Expeditors International of Washington, Inc., a Washington corporation, issued a press release announcing second quarter 2026 financial results" and the attached Exhibit 99.1 is labeled "EARNINGS RELEASE" with detailed financial metrics including diluted EPS of $2.03 (up 51%), net earnings of $266 million (up 45%), operating income of $350 million (up 41%), and revenues of $3.5 billion (up 32%). This is a material disclosure affecting investor assessment of the registrant's financial performance.
View raw filing on EDGAR →Red Rock Resorts issued a press release on August 4, 2026 disclosing second quarter 2026 financial results, including net revenues of $510.3 million (down 3.0% YoY), net income of $76.6 million (down 29.3% YoY), and Adjusted EBITDA of $208.0 million (down 9.3% YoY). The filing explicitly states "On August 4, 2026, the Registrant issued a press release" under Item 2.02 (Results of Operations and Financial Condition), with the press release attached as Exhibit 99.1 and incorporated by reference. This is a standard quarterly earnings disclosure material to investors.
View raw filing on EDGAR →This is a clear earnings release disclosing Syndax's financial results for Q2 2026 (quarter ended June 30, 2026), including total revenue of $73 million (92% YoY increase), Revuforj net revenue of $54.7 million (91% YoY increase), and Niktimvo collaboration revenue of $18.1 million (67% YoY increase). The press release and presentation are furnished as Exhibits 99.1 and 99.2 under Item 2.02, which is the standard Item for earnings disclosures. The results are material to investors as they demonstrate significant commercial traction for the company's two FDA-approved products.
View raw filing on EDGAR →The filing discloses the consummation of a transaction on August 3, 2026, in which Starwood formed a joint venture with Apollo Global Management involving approximately 120 affordable housing properties. Apollo invested $1.02 billion for 41.5% equity interests, while the Company retained 58.5% and operational control. This constitutes a material capital transaction and change in the ownership structure of a significant portion of the Company's portfolio, meeting the definition of ma_activity (entry into a material transaction involving a change of control or significant disposition of assets).
View raw filing on EDGAR →Seres Therapeutics entered into a lease termination and amendment agreement on July 31, 2026, to early-terminate approximately 31% of its Cambridge facility, reducing annual facilities costs and restoration obligations. The transaction involves material financial consideration including a $2.2M increase to letter of credit, a $3.85M deferred payment, and a $0.5M equity issuance (103,520 shares).
View raw filing on EDGAR →Personalis issued a press release on August 4, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $22.4 million (30% YoY growth), clinical revenue of $2.6 million (442% YoY growth), and clinical test volume of 10,384 tests (199% YoY growth). The filing includes consolidated statements of operations, balance sheets, and supplemental revenue information, all hallmarks of a quarterly earnings release under Item 2.02.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states "Tyra Biosciences, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2026," with the press release attached as Exhibit 99.1. The exhibit contains detailed financial results including cash position ($353.9M), R&D expenses ($39.2M), G&A expenses ($9.8M), and net loss ($45.6M), along with condensed balance sheets and operational highlights. This is a standard quarterly earnings disclosure material to investors assessing the company's financial condition and cash runway.
View raw filing on EDGAR →Green Thumb Industries issued a press release on August 4, 2026, announcing its financial results for the quarter ended June 30, 2026, disclosing revenue of $306.7 million (up 4.6% YoY), GAAP net income of $4.9 million ($0.02 per share), and normalized EBITDA of $84.3 million. The press release is attached as Exhibit 99.1 and constitutes a standard quarterly earnings disclosure under Item 2.02 (Regulation FD Disclosure).
View raw filing on EDGAR →TransMedics issued a press release on August 4, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing total revenue of $189.9 million (21% increase YoY), net income of $14.7 million ($0.41 per diluted share), and raising full-year 2026 revenue guidance to $737–$757 million. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1.
View raw filing on EDGAR →This is a press release announcing Stevanato Group's Q2 2026 financial results, including revenue of €302.0 million (8% growth), gross profit margin of 28.7%, and adjusted EBITDA margin of 26.0%. The release also discloses the completed divestiture of Balda C. Brewer, Inc. and updated full-year 2026 guidance. While the exhibit contains both an earnings announcement and a material M&A event (the subsidiary sale), the primary and dominant disclosure is the quarterly earnings release, which is material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →Zeta Global issued a press release on August 4, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing Q2 revenue of $443 million (44% Y/Y growth), positive GAAP net income of $8 million, and significantly increased full-year 2026 guidance across revenue, adjusted EBITDA, free cash flow, and EPS. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and forward outlook.
View raw filing on EDGAR →Sixth Street Specialty Lending disclosed Q2 2026 earnings results with net investment income of $0.43 per share, net income of $0.43 per share, and NAV per share of $16.24, along with comprehensive portfolio activity and debt metrics.
View raw filing on EDGAR →Idaho Power entered into a Terms Agreement on August 3, 2026 to sell $200,000,000 aggregate principal amount of 5.70% First Mortgage Bonds due 2055. This is a direct creation of a new financial obligation through debt issuance, with the bonds expected to close on August 6, 2026. The transaction is material as it increases the company's outstanding debt from $400 million to $600 million in this series.
View raw filing on EDGAR →Mercury General Corporation issued a press release on August 4, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing net income of $263.5 million (Q2 2026) versus $166.5 million (Q2 2025), net income per diluted share of $4.76 versus $3.01, and a combined ratio of 89.9% versus 92.5%. The filing includes detailed consolidated highlights, investment results, balance sheet information, and operating ratios. This is a standard quarterly earnings release with comprehensive financial metrics and results of operations.
View raw filing on EDGAR →Fortune Brands issued a press release on August 4, 2026 reporting Q2 2026 financial results, including net sales of $1.2 billion (down 4.1% YoY), GAAP EPS of ($0.19), and updated full-year 2026 guidance. The disclosure is a standard quarterly earnings announcement with detailed segment results, balance sheet metrics, and forward guidance, furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →This is a clear earnings release disclosing Ultragenyx's financial results for Q2 2026 (three and six months ended June 30, 2026), including total revenue of $214 million, net loss of $92 million, and detailed product revenue breakdowns. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing also reaffirms full-year 2026 guidance and discusses upcoming clinical and regulatory catalysts.
View raw filing on EDGAR →Vroom disclosed Q2 2026 financial results for the quarter ended June 30, 2026, achieving a historic milestone with positive net income of $0.6 million and adjusted net income of $1.5 million for the first time in company history. The disclosure includes detailed financial tables, segment results, and management commentary furnished as a press release with supplemental investor presentation materials.
View raw filing on EDGAR →OnKure Therapeutics issued a press release on August 4, 2026, reporting financial results for the quarter ended June 30, 2026, including R&D expenses of $12.6 million, G&A expenses of $4.3 million, net loss of $15.3 million ($0.31 per share), and cash position of $176.4 million. The filing explicitly discloses Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.
View raw filing on EDGAR →This exhibit is a Q2 2026 financial results presentation dated August 4, 2026, disclosing quarterly revenue of €280M (8% growth), adjusted EBITDA of €78.7M (21% growth), and adjusted diluted EPS of €0.14. The document presents segment performance, margin expansion, and updated full-year 2026 guidance, which are material to investors assessing the registrant's financial performance and outlook.
View raw filing on EDGAR →Devon Energy announced its second-quarter 2026 financial and operational results on August 4, 2026, with an earnings release and supplemental financial information furnished as Exhibits 99.1 and 99.2. The disclosure includes consolidated statements of earnings, cash flows, production data, capital expenditures, and forward-looking guidance—all hallmarks of a quarterly earnings release under Item 2.02. The company reported net earnings of $1.9 billion ($2.03 per diluted share) and core earnings of $1.5 billion ($1.57 per diluted share), along with operating cash flow of $3.7 billion and adjusted free cash flow of $1.7 billion.
View raw filing on EDGAR →BrightView issued a press release on August 4, 2026 reporting unaudited results for the third quarter ended June 30, 2026, disclosing net service revenues of $717.6 million, net income of $6.1 million, and Adjusted EBITDA of $96.1 million, along with updated fiscal year 2026 guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02 of Form 8-K.
View raw filing on EDGAR →Champion Homes issued a press release on August 4, 2026, disclosing financial results for the first quarter fiscal 2027 ended June 27, 2026, including net sales of $710.2 million, gross profit margin of 25.2%, EPS of $0.89, and adjusted EBITDA of $73.6 million. The Board also approved a $50 million increase to the share repurchase program.
View raw filing on EDGAR →This is a clear earnings release disclosing Revolve Group's second quarter 2026 financial results, including net sales of $347.4 million (12% YoY growth), net income of $18.6 million (86% YoY growth), and operational metrics such as active customer growth of 11%. The press release is furnished as Exhibit 99.1 to the 8-K under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes detailed financial summaries, segment performance, cash flow analysis, and forward guidance for Q3 and full-year 2026.
View raw filing on EDGAR →Palomar Holdings issued a press release on August 4, 2026, announcing Q2 2026 financial results including net income of $52.6 million ($1.94 per diluted share), adjusted net income of $63.8 million ($2.36 per diluted share), gross written premiums of $630.5 million (27% increase), and full-year 2026 adjusted net income guidance of $270–$280 million.
View raw filing on EDGAR →The Board declared Palomar's initial quarterly cash dividend of $0.45 per common share, payable September 2, 2026, representing the company's first regular dividend and a material capital allocation decision supported by strong Q2 2026 earnings.
View raw filing on EDGAR →This Item 7.01 disclosure furnishes a Capital Markets Update presentation covering MAA's operating performance, development pipeline, market positioning, and strategic initiatives (ReiMAAgine platform, redevelopment programs, technology-enabled operations). While the presentation includes financial metrics and operational updates, it is a forward-looking strategic and operational overview rather than a discrete material event (earnings release, M&A, impairment, etc.). The disclosure is material to investors as it communicates the company's strategic direction, development pipeline expansion, and operational improvements, but the event type is operational strategy and business positioning rather than a specific named category.
View raw filing on EDGAR →PG&E completed the sale of $1.7 billion in First Mortgage Bonds ($700M due 2032 at 5.250% and $1B due 2036 at 5.850%) on August 4, 2026. This is a material creation of direct financial obligations through debt issuance, disclosed under Item 8.01 (Other Events). The magnitude and nature of the transaction—entry into an underwriting agreement followed by completion of the bond sale—clearly constitute a debt issuance event material to investors.
View raw filing on EDGAR →This is a clear earnings release disclosing Gladstone Capital's financial results for the fiscal quarter ended June 30, 2026. The press release, filed as Exhibit 99.1 to the 8-K Item 2.02, presents comprehensive quarterly financial data including net investment income ($11.0 million, $0.49 per share), net asset value per share ($21.50), portfolio metrics, and management commentary. The disclosure is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →Matthew Pasch, Executive Vice President and Chief Human Resources Officer, is departing effective September 1, 2026. The disclosure includes severance and equity vesting details related to his departure.
View raw filing on EDGAR →John Pershing is appointed as Executive Vice President and Chief Human Resources Officer, effective October 2026, succeeding Matthew Pasch. Pershing brings extensive HR leadership experience from major retailers including Barnes & Noble, Canadian Tire, Ascena, and Best Buy.
View raw filing on EDGAR →Dr. Jeffrey A. Graves, the Company's President and Chief Executive Officer and Board member, is departing the Company and retiring from the Board effective upon hiring a successor. The filing discloses severance and consulting arrangements in connection with his departure.
View raw filing on EDGAR →This is a straightforward earnings release disclosing Acadia's financial results for the six months ended June 30, 2026. The press release (Exhibit 99.1) reports Q2 2026 revenues of $308 million (up 16% YoY), net income of $32 million, and updated full-year 2026 guidance to $1.24–$1.30 billion in total revenues. The filing explicitly states this is furnished under Item 2.02 (Results of Operations and Financial Condition), the standard Item for earnings disclosures.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 financial results. The Item 2.02 disclosure describes Kodak's second quarter 2026 financial results, including consolidated revenues of $311 million (18% YoY increase), gross profit of $82 million (61% increase), GAAP net income of $17 million (vs. a $26 million loss in Q2 2025), and Operational EBITDA of $36 million. The press release is furnished as Exhibit 99.1 and includes detailed financial statements and segment performance data. This represents material financial results that would affect a reasonable investor's assessment of the company's performance and trajectory.
View raw filing on EDGAR →The filing discloses Alphatec's second quarter 2026 financial results via a press release issued on August 4, 2026, as indicated in Item 2.02. The press release reports total revenue of $214 million (up 15% YoY), surgical revenue of $196 million (up 17%), GAAP net loss of ($26) million, and adjusted EBITDA of $36 million, along with reaffirmed and increased 2026 full-year guidance. This is a standard earnings release disclosure material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →The Company entered into a Fourth Amended and Restated Credit Agreement on August 3, 2026, extending the maturity date to August 3, 2031, and increasing aggregate borrowing capacity from $100 million to $125 million.
View raw filing on EDGAR →The Hackett Group issued a press release on August 4, 2026 disclosing consolidated financial results for the second fiscal quarter ended June 26, 2026, including revenue of $69.3M, GAAP diluted EPS of $0.18, adjusted diluted EPS of $0.34, and forward guidance for Q3 2026.
View raw filing on EDGAR →Getaround, Inc. filed a Certificate of Dissolution with Delaware on July 29, 2026, following stockholder approval at a special meeting, and is proceeding with orderly liquidation under a Plan of Distribution. The company expects no available proceeds for stockholder distributions after satisfying debt and liabilities, effectively terminating the registrant's continued existence.
View raw filing on EDGAR →Viasat disclosed its first quarter fiscal year 2027 financial results on August 4, 2026, including revenue of $1.2 billion (down 1% YoY), net loss of $52 million (improved from $56 million in Q1 FY2026), and adjusted EBITDA metrics. The disclosure includes a press release (Exhibit 99.1) and a detailed shareholder letter (Exhibit 99.2) with comprehensive financial and operational commentary, which is the standard format for an earnings release under Item 2.02.
View raw filing on EDGAR →General Dynamics filed a prospectus supplement on August 4, 2026 relating to a rescission offer for up to 1,010,925 shares of common stock under an automatic shelf registration statement. While the filing involves capital markets activity and a rescission offer (potentially signaling prior share issuance issues), the disclosure does not clearly fit established categories: it is not a standard dilutive issuance (which typically involves new equity sales), nor a debt issuance, dividend, or other named financial event. The rescission offer itself—an offer to unwind a prior share acquisition—is unusual and material to investors assessing the company's capital structure and prior transactions, but lacks a precise taxonomic home.
View raw filing on EDGAR →